FOCL
EDAP TMS S.A. American Depositary Shares
FOCL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
FOCL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Healthy |
FOCL's balance sheet is currently healthy, but its revenue, profitability and cash flow are under pressure.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
FOCL PE Valuation
FOCL has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
FOCL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect FOCL's losses to shrink, with revenue declining.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
FOCL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.98 | -$0.39 |
| Q2 2024 | -$0.58 | -$0.07 |
| Q1 2024 | -$0.54 | -$0.23 |
| Q4 2023 | -$0.63 | -$0.55 |
| Q3 2023 | -$0.63 | -673% |
| Q2 2023 | -$0.51 | -738% |
| Q1 2023 | -$0.31 | -3200% |
| Q4 2022 | -$0.08 | -500% |
FOCL lost $0.98 per share over the past year, a bigger loss than the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over FOCL on earnings, with more consistent year-over-year improvement.
FOCL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $9.8M | -39% |
| Q2 2026 | $13.2M | -27% |
| Q1 2026 | $17.8M | +25% |
| Q4 2025 | $21.9M | +0.9% |
| Q2 2025 | $18.2M | +7% |
| Q1 2025 | $14.3M | -12% |
| Q4 2024 | $21.7M | +2.8% |
| Q2 2024 | $17M | +9.4% |
FOCL's revenue is shrinking: $10M last quarter, down 39% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -79% | -44 points |
| Q2 2026 | -61% | -25 points |
| Q1 2026 | -41% | +2.9 points |
| Q4 2025 | -28% | -9.1 points |
| Q3 2025 | -35% | N/A |
| Q2 2025 | -36% | +3 points |
| Q1 2025 | -44% | -12 points |
| Q4 2024 | -18% | -0.6 points |
FOCL's operating margin was −79% last quarter, down 44 points from the same quarter a year ago, near the bottom of its range since 2015.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over FOCL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over FOCL on profitability, with a higher operating margin.
FOCL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$4M | +$891.5K |
| Q2 2026 | -$3.7M | +$2.4M |
| Q1 2026 | -$3M | +$3.7M |
| Q4 2025 | -$4.1M | -$3.4M |
| Q3 2025 | -$4.9M | +$1.6M |
| Q2 2025 | -$6.1M | +$1.4M |
| Q1 2025 | -$6.6M | -$1.4M |
| Q4 2024 | -$642.7K | +$1.4M |
FOCL has burned cash in most quarters: −$15M over the past year, against −$18M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over FOCL on cash generation, producing positive trailing cash flow while its opponent burns cash.
FOCL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +14% | +5.1M shares |
| 1 year | +14% | +5.2M shares |
| 3 years | +15% | +5.6M shares |
| 5 years | +32% | +10.4M shares |
| Available history | +58% | +15.6M shares |
FOCL has 43M diluted shares, up 14% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over FOCL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
FOCL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2022 | -12.2x | Net Cash |
| Q2 2022 | -13.3x | Net Cash |
| Q1 2022 | -85.7x | Net Cash |
| Q4 2021 | -148.8x | Net Cash |
| Q3 2021 | -49.2x | Net Cash |
| Q2 2021 | -27.7x | Net Cash |
FOCL has more cash than debt.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
FOCL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.0 | Neutral |
| Stochastic | 4.9 | Oversold |
FOCL's weekly RSI is 38 (neutral) and its Stochastic is 5 (oversold).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
FOCL PE vs Healthcare Sector
| Metric | FOCL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
FOCL has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
FOCL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.03 | 15% below |
| 20 week MA | $4.62 | 26% below |
| 50 week MA | $4.20 | 19% below |
| 100 week MA | $3.12 | 9.3% above |
| 200 week MA | $4.98 | 32% below |
FOCL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
FOCL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4.40 | $5.08 | +15% |
| 2021 | $5.08 | $5.65 | +11% |
| 2022 | $5.65 | $10.5 | +86% |
| 2023 | $10.5 | $5.28 | -50% |
| 2024 | $5.28 | $2.17 | -59% |
| 2025 | $2.17 | $3.40 | +57% |
| 2026 YTD | $3.40 | $3.41 | +0.3% |
FOCL has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.